Health Condition 1: null- Patients with Chronic Periodontitis
Conditions
Interventions
Intervention1: Inersan: Lactobacillus brevis CD2 1000000000 Colony Forming Units/gm Lozenges Twice daily for 14 days
Intervention2: Inersan and Tab. Doxt 100mg: Inersan-Lactobacillus brevis CD2 100000
Sponsors
Sree Mookambika Institute of Dental Sciences
Eligibility
Inclusion criteria
Inclusion criteria: -AAP International Workshop for Classification of Periodontal Diseases,1999. -Subjects of both sexes -Patients in the age group of 25-60 years -Subjects with mild to moderate chronic periodontitis, as defined by probing pocket depths >=5mm in > 30 % of the probing sites. -Subjects in good general health
Exclusion criteria
Exclusion criteria: -Antibiotic therapy in the past 2 months - Allergic to doxycycline or probiotics. -Subjects with diabetic mellitus,hypertension and psychiatric disorders -Subjects who are pregnant/ lactating -Smokers and/or alcoholics. -Those undergone any periodontal therapy within last 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Load of Lacto bacillus will be increased in Probiotic InersanTimepoint: One Month | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in clinical outcome and decrease in P. gingivalis count in all three groupsTimepoint: One month | — |
Countries
India
Contacts
Public ContactDr AryaKS
Sree Mookambika Institute of Dental Sciences
Outcome results
None listed